HPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heidelberg Pharma AG

Watchlist Manager

Watchlist

Price: 2.61 EUR Market Closed

Market Cap: €121.6m

H	Heidelberg Pharma AG XMUN:HPHA	DE
P	Porr AG XMUN:ABS2	AT
	Moelis & Co NYSE:MC	US
B	Barnes & Noble Education Inc F:2BN	US
	Coway Co Ltd KRX:021240	KR
C	CyberAgent Inc SWB:CL2	JP

Profitability Summary

Heidelberg Pharma AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

77%

Gross Margin is Increasing

62% > 81%

Negative Operating Margin

-3 145%

Negative 3Y Average Operating Margin

-600%

Declining Operating Margin

-245% > -3 145%

Negative Net Margin

-2 901%

Negative 3Y Average Net Margin

-560%

Declining Net Margin

-247% > -2 901%

Negative Free Cash Flow Margin

-2 178%

Negative 3Y Average Free Cash Flow Margin

-623%

Declining Free Cash Flow Margin

-322% > -2 178%

Negative ROE

-424%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

Declining ROIC

-178% > -225%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.